The latest research report by Emergen Research, titled ‘Global Biobanking Market – Forecast to 2033’, presents an in-depth analysis of the global Biobanking Market. This detailed study covers essential business aspects such as key definitions, end-use applications, and total revenue generated across major regions. The research team has closely monitored top performers in the Biobanking Market, with a focus on import and export trends, demand and supply dynamics, gross margin analysis, supply chain management, and distribution channels.
Biobanking Market Overview and Growth Forecast
- The global biobanking market size was valued at USD 83.05 billion in 2024 and is expected to reach USD 182 billion by 2034, registering a CAGR of 8.16% from 2025 to 20347.
- Market growth is driven by the rising demand for high-quality biological samples in medical research, increasing prevalence of chronic diseases, and the expanding focus on personalized medicine and genomics.
- The integration of advanced storage technologies, such as automated sample management and virtual biobanking, is enhancing efficiency and reliability, further propelling market expansion.
- Significant investments from government and private sectors, coupled with the growing application of biobanked samples in drug discovery, disease diagnostics, and regenerative medicine, are key contributors to market growth.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/926
Market Drivers and Trends
- Rising investments in biobanking infrastructure and research from both public and private entities.
- Expansion of application areas for biobanked samples, especially in genomics, proteomics, and chronic disease management.
- Technological advancements in storage, automation, and data management systems, such as cryogenic storage and laboratory information management systems (LIMS).
- Growing focus on virtual biobanking and digital integration to support global research collaborations.
- Supportive government initiatives for regenerative medicine and personalized healthcare.
Biobanking Market Segmentation Analysis
By Product
- Equipment (cryogenic storage systems, freezers, refrigerators, alarms, monitoring systems)
- Consumables
- Services
By Biospecimen
- Human Tissues
- Blood Products
- Cell Lines
- Others
By Biobank Type
- Physical Biobanks
- Virtual Biobanks
By Application
- Drug Discovery & Clinical Research
- Disease Diagnostics
- Regenerative Medicine
- Others
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Hospitals
- Others
Regional Outlook (Revenue, USD Billion; 2024-2034)
Region | 2024 Market Size | 2034 Forecast | Key Notes |
Europe | USD 29.90 Bn | USD 66.43 Bn | Largest market, strong infrastructure |
North America | ~32% share | — | High R&D, advanced healthcare |
Asia-Pacific | — | — | Fastest growth, rising investments |
Latin America | — | — | Emerging market |
Middle East & Africa | — | — | Growing interest, infrastructure development |
Competitive Landscape
The report provides a detailed analysis of the competitive landscape, profiling key companies in the Biobanking Market with a focus on their global positioning, financial status, and recent strategic developments. Major players include:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Qiagen N.V.
- Brooks Automation
- Hamilton Company
- Tecan Group Ltd.
- Becton Dickinson and Company
- Promega Corporation
- Worthington Industries
- Chart Industries
- TTP Labtech Ltd.
- VWR Corporation
To know more about the report, click here @ https://www.emergenresearch.com/industry-report/biobanking-market
Key Benefits of Buying the Global Biobanking Market Report:
- Comprehensive analysis of the evolving competitive landscape
- Supports strategic planning and informed business decision-making
- Provides a 10-year forecast and market assessment
- Detailed insights into key product segments and their projected growth rates
- In-depth analysis of market drivers, restraints, trends, and opportunities
- Extensive regional analysis of the global Biobanking Market
- Thorough profiling of key industry stakeholders
- Detailed examination of factors influencing market growth
Request customization on the report @ https://www.emergenresearch.com/request-for-customization/926
Thank you for reading our report. To know more about the customization of the report, please get in touch with us, and our team will ensure the report is suited to your requirements.
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services